DOP2010000302A - Antagonistas de la trayectoria hedgehog de ftalazina disustituida - Google Patents

Antagonistas de la trayectoria hedgehog de ftalazina disustituida

Info

Publication number
DOP2010000302A
DOP2010000302A DO2010000302A DO2010000302A DOP2010000302A DO P2010000302 A DOP2010000302 A DO P2010000302A DO 2010000302 A DO2010000302 A DO 2010000302A DO 2010000302 A DO2010000302 A DO 2010000302A DO P2010000302 A DOP2010000302 A DO P2010000302A
Authority
DO
Dominican Republic
Prior art keywords
hedgehog
trajectory
antagonists
ftalazina
disttituted
Prior art date
Application number
DO2010000302A
Other languages
English (en)
Spanish (es)
Inventor
Philip Arthur Hipskind
Takako Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DOP2010000302A publication Critical patent/DOP2010000302A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DO2010000302A 2008-04-29 2010-10-11 Antagonistas de la trayectoria hedgehog de ftalazina disustituida DOP2010000302A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4872908P 2008-04-29 2008-04-29

Publications (1)

Publication Number Publication Date
DOP2010000302A true DOP2010000302A (es) 2010-11-15

Family

ID=40846962

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2010000302A DOP2010000302A (es) 2008-04-29 2010-10-11 Antagonistas de la trayectoria hedgehog de ftalazina disustituida

Country Status (22)

Country Link
US (1) US7981892B2 (OSRAM)
EP (1) EP2294061A2 (OSRAM)
JP (1) JP5442717B2 (OSRAM)
KR (1) KR101260116B1 (OSRAM)
CN (1) CN102066353B (OSRAM)
AU (1) AU2009241561B2 (OSRAM)
BR (1) BRPI0911618A2 (OSRAM)
CA (1) CA2723042A1 (OSRAM)
CO (1) CO6300945A2 (OSRAM)
CR (1) CR11741A (OSRAM)
DO (1) DOP2010000302A (OSRAM)
EA (1) EA201071248A1 (OSRAM)
EC (1) ECSP10010577A (OSRAM)
HN (1) HN2010002157A (OSRAM)
IL (1) IL208211A0 (OSRAM)
MA (1) MA32349B1 (OSRAM)
MX (1) MX2010011948A (OSRAM)
MY (1) MY159491A (OSRAM)
NZ (1) NZ588001A (OSRAM)
UA (1) UA102250C2 (OSRAM)
WO (1) WO2009134574A2 (OSRAM)
ZA (1) ZA201006695B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201071248A1 (ru) 2008-04-29 2011-06-30 Эли Лилли Энд Компани Дизамещенные фталазиновые антагонисты пути hedgehog
HRP20130527T1 (en) * 2008-11-03 2013-07-31 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
CA2743483C (en) 2008-11-17 2014-03-11 Eli Lilly And Company Tetrasubstituted pyridazine hedgehog pathway antagonists
CA2743264C (en) 2008-11-17 2014-02-18 Julia Marie Clay Tetrasubstituted pyridazines hedgehog pathway antagonists
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
PH12012500911A1 (en) * 2009-11-18 2012-11-26 Novartis Ag Methods and compositions for treating solid tumors and other malignancies
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
WO2014043608A2 (en) * 2012-09-17 2014-03-20 Duke University Smoothened modulators and methods of use thereof
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
GB201309508D0 (en) 2013-05-28 2013-07-10 Redx Pharma Ltd Compounds
GB2528298A (en) * 2014-07-16 2016-01-20 Redx Pharma Plc Compounds
CN105985321B (zh) * 2015-02-11 2018-10-26 复旦大学 吡唑酞嗪化合物及其制备方法和用途
CN105985320B (zh) * 2015-02-11 2018-10-26 复旦大学 苄基酞嗪化合物及其制备方法和用途
CN105985319B (zh) * 2015-02-11 2019-02-26 复旦大学 芳基酞嗪化合物及其制备方法和用途
CN107163028B (zh) * 2017-05-24 2019-07-12 东南大学 一种苯甲酰胺类Hedgehog抑制剂及其制备方法和应用
JP2023546536A (ja) 2020-10-13 2023-11-02 エンデバー バイオメディシンズ， インコーポレイテッド 線維症を処置する方法
US20240124451A1 (en) * 2022-09-23 2024-04-18 Merck Sharp & Dohme Llc Phthalazine derivatives useful as inhibitors of nod-like receptor protein 3
WO2025188802A1 (en) 2024-03-05 2025-09-12 Endeavor Biomedicines, Inc. Methods of improving lung function

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
JP4169368B2 (ja) 1996-01-15 2008-10-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 脈管形成阻害性ピリダジンアミン
US6432970B2 (en) * 1998-04-09 2002-08-13 Johns Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
EP1067939B1 (en) 1998-04-09 2015-09-16 The Johns Hopkins University Use of steroidal alkaloid derivatives as inhibitors of hedgehog protein signaling pathways
DE60016402T2 (de) 1999-06-08 2005-10-27 Lorantis Ltd. Therapeutische verwendung eines inhibitors des hedgehog signalübertragungsweges
EP1496905B1 (en) 2002-04-22 2008-08-13 Johns Hopkins University School of Medicine Modulators of hedgehog signaling pathways, compositions and uses related thereto
AU2003265853A1 (en) 2002-08-29 2004-03-19 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
US8067608B2 (en) 2003-09-29 2011-11-29 The Johns Hopkins University Hedgehog pathway antagonists
WO2005080378A1 (ja) 2004-02-24 2005-09-01 Mitsubishi Pharma Corporation 縮合ピリダジン誘導体
CN1984904A (zh) 2004-05-08 2007-06-20 神经能质公司 3－芳基－5,6－二取代哒嗪
EP1789390B1 (en) 2004-09-02 2011-11-09 Genentech, Inc. Pyridyl inhibitors of hedgehog signalling
EP1900731A1 (de) 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
AU2008225766B2 (en) * 2007-03-15 2012-06-07 Novartis Ag Organic compounds and their uses
AU2008269128B2 (en) * 2007-06-25 2012-08-02 Amgen Inc. Phthalazine compounds, compositions and methods of use
AU2008300019A1 (en) 2007-09-07 2009-03-19 Amgen Inc. Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
EA201071248A1 (ru) 2008-04-29 2011-06-30 Эли Лилли Энд Компани Дизамещенные фталазиновые антагонисты пути hedgehog
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
HRP20130527T1 (en) 2008-11-03 2013-07-31 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
CA2743264C (en) 2008-11-17 2014-02-18 Julia Marie Clay Tetrasubstituted pyridazines hedgehog pathway antagonists
CA2743483C (en) 2008-11-17 2014-03-11 Eli Lilly And Company Tetrasubstituted pyridazine hedgehog pathway antagonists
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer

Also Published As

Publication number Publication date
JP5442717B2 (ja) 2014-03-12
CR11741A (es) 2011-01-05
KR101260116B1 (ko) 2013-05-02
MA32349B1 (fr) 2011-06-01
HN2010002157A (es) 2014-09-08
MY159491A (en) 2017-01-13
US7981892B2 (en) 2011-07-19
ECSP10010577A (es) 2010-11-30
AU2009241561B2 (en) 2013-05-16
ZA201006695B (en) 2012-09-26
CN102066353B (zh) 2013-12-11
EA201071248A1 (ru) 2011-06-30
CO6300945A2 (es) 2011-07-21
CN102066353A (zh) 2011-05-18
UA102250C2 (ru) 2013-06-25
EP2294061A2 (en) 2011-03-16
US20110046143A1 (en) 2011-02-24
IL208211A0 (en) 2010-12-30
AU2009241561A1 (en) 2009-11-05
KR20100126580A (ko) 2010-12-01
NZ588001A (en) 2012-06-29
WO2009134574A3 (en) 2014-09-04
JP2011527666A (ja) 2011-11-04
CA2723042A1 (en) 2009-11-05
MX2010011948A (es) 2010-12-14
WO2009134574A2 (en) 2009-11-05
BRPI0911618A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
DOP2010000302A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
DOP2011000386A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
MX346924B (es) Compuestos de diarilhidantoina.
ECSP11011021A (es) Antagonistas de la via hedgehog de ftalazina disustituida
HN2011002809A (es) Compuestos de vinil indazolilo
UY31432A1 (es) Compuestos de diarilhidantoina
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
EA201001639A1 (ru) Композиции и способы их получения и применения
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
DOP2011000009A (es) Amidofenoxiindazoles utiles como inhibidores de c-met
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
CR20120202A (es) Métodos y composiciones para tratar cáncer
CL2010001474A1 (es) Compuestos derivados de tiofeno o tiazol sustituidos, inhibidores de pi3k; composicion farmaceutica; utiles en el tratamiento del cancer, inflamacion y en el tratamiento de trastornos cardiovasculares.
CR11299A (es) Amidas heterociclicas utiles para el tratamiento de cancer y psoriasis
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
UY32882A (es) (heteroarilmetil) tiohidantoínas sustituidas
CR20120213A (es) Métodos para el tratamiento del cáncer usando antagonistas de notch
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
PA8851101A1 (es) Compuesto amino pirazol
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
CU24011B1 (es) Piperidinas 2-fenil-5-(1,2,4-oxadiazol-5-il) sustituidas
EA200970816A1 (ru) Новая лекарственная форма
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
CL2011002967A1 (es) Compuestos derivados de 3-oxadiazolil-5-fenil-piperidina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamient y/o profilaxis de trastornos cardiovasculares, tromboembolicos y tumorales.